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Satb1 and Satb2 have been recently described as
regulators of embryonic stem (ES) cell pluripotency
and as silencing factors in X chromosome inactiva-
tion. The influence of the pluripotency machinery on
X chromosome inactivation and the lack of an X chro-
mosome inactivationdefect inSatb1/andSatb2/
mice raise the question of whether or not Satb
proteins are directly and/or redundantly involved in
this process. Here, we analyzed X chromosome inac-
tivation in fibroblastic cells that were derived from
female Satb1/Satb2/ embryos. By fluorescence
in situ hybridization to visualize Xist RNA and by
immunohistochemistry to detect H3K27me3 histone
modifications, we found that female Satb1/
Satb2/ fibroblastic cells contain proper Barr
bodies. Moreover, we did not detect an upregulation
of X-linked genes, suggesting that Satb proteins are
dispensable for X chromosome inactivation in mice.
INTRODUCTION
X chromosome inactivation (XCI) is the process by which female
mammals achieve an equal ratio of X chromosomal to autosomal
gene expression compared to male cells (Chow and Heard,
2009; Payer and Lee, 2008). Random XCI can be observed in
early embryos (around E6.5) in vivo or in differentiating embry-
onic stem (ES) cells in vitro (Payer and Lee, 2008). Although
pluripotent cells are not the only cells that can initiate XCI, they
are the only cells that actually undergo endogenous X chromo-
some inactivation (Chow et al., 2007; Hall et al., 2002; Savarese
et al., 2006). Notably, recent reports implicated the pluripotency
machinery of ES cells in the regulation of key determinants of
XCI, the noncoding RNA Xist and its antagonist Tsix (Donohoe
et al., 2009; Navarro et al., 2008, 2010). Xist coats the inactive
X chromosome (Xi) in cis, leading to a series of epigenetic
modifications that are thought to act redundantly in the mainte-
nance of a transcriptionally silent state (Brockdorff et al., 1992;
Kohlmaier et al., 2004; Schoeftner et al., 2006).
Proteins required for the silencing of the inactive X chromo-
some were only recently identified. SmcHD1, a protein with
a structural-maintenance-of-chromosomes (SCM) hinge domain
characteristic of proteins involved in chromosome condensation866 Developmental Cell 23, 866–871, October 16, 2012 ª2012 Elsevand cohesion, was implicated in the maintenance of the silent
state of the Xi (Blewitt et al., 2008). Embryos lacking SmcHD1
show defective XCI in vivo (Blewitt et al., 2008). However,
SmcHD1-deficient female embryos display a rather late embry-
onic lethality, and hence it is thought that SmcHD1 plays a role
in the maintenance of the silent state of the Xi, rather than in
the initiation of silencing. Recently, the chromatin organizer
Satb1 was identified as a critical regulator of Xist-mediated
silencing (Agrelo et al., 2009; Cai et al., 2003). Differential gene
expression profiling of Xist-resistant and Xist-sensitive T cell
lymphomas identified Satb1 among several genes that were
specifically expressed in silencing-competent lymphomas
(Agrelo et al., 2009). Moreover, Satb1 knockdown experiments
in pluripotent ES cells and overexpression studies, in which
Satb1 was found to confer upon fibroblasts the ability of initiating
de novo XCI, suggested a role of Satb1 in the initiation of XCI
(Agrelo et al., 2009). However, Satb1/ female embryos do
not display early lethality associated with aberrant XCI, raising
the possibility of a functional redundancy with the closely
related Satb2 protein (Dobreva et al., 2003, 2006). Both Satb1
and Satb2 are expressed at the onset of XCI in ES cell differen-
tiation; however, the analysis of a potential functional redun-
dancy of Satb1 and Satb2 was precluded by the inability to
generate stable Satb1/Satb2 double knockdown ES cells (Agrelo
et al., 2009).
Satb1 and Satb2 were also shown to regulate the pluripotency
of ES cells, whereby Satb1 and Satb2 play an opposite role in the
regulation of ES cell pluripotency and Nanog gene expression
(Savarese et al., 2009). In particular, Satb1 was shown to repress
Nanog, whereas Satb2 was found to activate Nanog. An antag-
onistic role of Satb proteins in the regulation of Nanog was also
inferred from the analysis of Satb1/Satb2/ ES cells, which
showed a less severe defect in self-renewal and differentiation
than the corresponding single knockout ES cells (Savarese
et al., 2009). Recently, these findings were independently
confirmed by a small hairpin RNA (shRNA) screen (Kagey
et al., 2010). Regulators of ES cell pluripotency, such as Oct4,
have been found to indirectly regulate XCI (Donohoe et al.,
2009; Navarro et al., 2008, 2010), raising the question of whether
Satb1 and Satb2 modulate Xist expression via the pluripotency
machinery, which restricts the potential of a cell to initiate Xist-
mediated gene silencing.
To better understand the roles of Satb1 and Satb2 in XCI, we
analyzed dosage compensation and the Xi in E13.5 mouse
embryonic fibroblasts (MEFs) generated from Satb1/,
Satb2/, and Satb1/Satb2/ female mice. We found thatier Inc.
Table 1. Statistics of the Genotypes of E13.5 Embryos Derived
from Satb1+/–Satb2+/– Intercrosses
Satb1 Satb2 n
+/+ +/+ 4
+/+ +/ 24
+/+ / 15
+/ +/+ 17
+/ +/ 53
+/ / 34
/ +/+ 12
/ +/ 30
/ / 7
total 196
Of seven Satb1/Satb2 double-deficient embryos, three were female and
four were male. Most Satb1/Satb2 double-mutant mice die independent
of their sex after day 14.5, without showing any obvious phenotypic
abnormalities at E13.5.
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Proper XCI in the Absence of Satb Proteinsfemale Satb1/Satb2/ MEFs contained a normal Barr body
and were properly dosage compensated, suggesting that
Satb1 and Satb2 are dispensable for XCI in vivo.
RESULTS AND DISCUSSION
Female Satb1/Satb2 Double-Deficient Embryos
Are Viable
To examine a potential redundancy of Satb1 and Satb2 in the
process of XCI, we generated E13.5 MEFs from intercrosses of
Satb1+/Satb2+/ animals (Alvarez et al., 2000; Dobreva et al.,
2006). Upon culture, we determined the genotype and sex of
the embryos by PCR analysis (see Figure S1A available online).
Because mutations in genes required for XCI result in early
embryonic lethality around E6.5, we were surprised about the
presence of female Satb1–/–Satb2/ embryos at day E13.5,
from which we could derive MEFs (Table 1). Multiple rounds of
genotyping confirmed that these cells were female and deficient
for both Satb1 and Satb2 (Figure S1 and data not shown).
Among 196 embryos, we detected three female and four male
Satb1/Satb2/ embryos, slightly less than the expected six
plus six embryos according to Mendelian inheritance. These
findings indicate that XCI can be initiated during embryogenesis
in the absence of both Satb1 and Satb2.
Satb1–/–Satb2–/– MEFs Display Proper Cytological and
Molecular Features of X Chromosome Inactivation
To examinewhether the targeted inactivation ofSatb1 andSatb2
influences the cytological manifestations of the Xi, we analyzed
the Barr-body in female wild-type, Satb1/ and Satb2/
single-mutant MEFs, Satb1/Satb2/ double-mutant MEFs,
and male wild-type MEFs, which served as a negative control.
We performed Xist RNA fluorescence in situ hybridization
(FISH) and immunfluorescence (IF) staining against H3K27me3,
a well-described mark of the Xi (Kohlmaier et al., 2004; Plath
et al., 2003). The localization of Xist and the pattern of
H3K27me3 were normal not only in wild-type, Satb1/, and
Satb2/ female MEFs, but also in Satb1/Satb2/ femaleDevelopmMEFs (Figure 1A). Moreover, the analysis of the frequencies of
cells with focal staining of Xist and H3K27me3 did not reveal
significant differences between the various genotypes (Fig-
ure 1B). Thus, we failed to detect cytological manifestations of
aberrant XCI, consistent with the similar growth rates of the
wild-type, Satb/, and Satb1/Satb2/ MEFs (data not
shown). Because MEFs do not express Satb1 and Satb2 at
a detectable level, these proteins do not appear to be required
for Xist localization in these cells.
Focal Xist localization and H3K27me3 staining are cytological
manifestations of the Xi but are not direct molecular readouts of
a transcriptionally silent chromosome (Plath et al., 2003).Without
proper dosage compensation, female embryos do not survive
until E13.5, and they preclude the derivation of MEFs (Marahrens
et al., 1997; Penny et al., 1996). To examine potential conse-
quences of the Satb1 and Satb2 deficiencies on the silencing
process itself, we analyzed gene expression of X-linked and
autosomal genes in female wild-type, Satb1/, Satb2/, and
two independent lines of Satb1/Satb2/ MEFs, as well as in
male wild-type MEFs. Analysis of Pgk1 andHprt, genes normally
silent on the Xi, revealed no dosage imbalance between these
transcripts and those of the autosomal gene Gapdh in female
wild-type, Satb1/, Satb2/, and Satb1/Satb2/ MEFs
compared to male wild-type MEFs (Figure 2). Pgk1 expression
was slightly lower in Satb2/MEFs than in the other cells, which
might be explained by the slightly slower growth of Satb2/
MEFs. In addition, we analyzed the expression of Xist and found
that it was normally expressed in female MEFs of all genotypes
examined (Figure 2).
No Evidence for Residual Satb1 or Satb2 Expression
in Satb1/Satb2 Double-Deficient MEFs
To examine whether or not the targeted mutations of Satb1 and
Satb2 allow for the generation of protein with residual activity, we
analyzed both protein and RNA expression in wild-type and
mutant cells. The mutation of the Satb1 allele removes exons
1–5, encoding the PDZ dimerization domain (Alvarez et al.,
2000). A truncated protein could theoretically be produced by
translation from an in-frame ATG in exon 6 (Figure S2A).
However, such a putative truncated form of Satb1 would not
dimerize and would be severely impaired in its DNA-binding
efficiency (Purbey et al., 2008). By immunoblot analysis with
a previously published polyclonal anti-Satb1 antiserum that
also detects epitopes in the C-terminal half of Satb1 and has
some cross-reactivity toward the closely related Satb2 protein
(Figures S2B–S2D), no truncated form of Satb1 was detected
in Satb1/ and Satb1/Satb2/ ES cells (Figure S2B). In
undifferentiated and differentiating Satb1/Satb2/ cells,
grown in LIF- and retinoic acid-containing medium, respectively,
we also failed to detect Satb1 transcripts encoding the PDZ
domain or the DNA-binding domain (Figure S2E). Likewise, the
Satb2 allele, used for the generation of Satb1/Satb2/
mice, is most likely a null allele, because it generates virtually
the same mutant phenotype as a different mutant Satb2 allele
that was generated by a different targeting strategy (Alcamo
et al., 2008; Britanova et al., 2008). Taken together, these
data suggest that the lack of a defect of X inactivation in
Satb1/Satb2/ mice cannot be explained by residual Satb1
and/or Satb2 activity.ental Cell 23, 866–871, October 16, 2012 ª2012 Elsevier Inc. 867
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Figure 1. Satb1 and Satb2 Are Dispensable
for Barr Body Formation
(A) Xist RNA FISH and H3K27me3 immunofluo-
rescence stainings reveal normal focal Xist and
H3K27me3 signals in female Satb1/, Satb2/,
and Satb1/Satb2/ MEFs.
(B) Statistical analysis of cells displaying focal Xist
or focal H3K27me3 staining. For each cell type and
staining, more than 100 individual nuclei were
analyzed.
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Inactivation In Vivo
Our findings that female embryos are properly dosage compen-
sated in the absence of both Satb1 and Satb2 in vivo raise issues
about the roles of these proteins in XCI in ES cells. Although the
targeted inactivation of both Satb1 and Satb2 does not signifi-
cantly affect cell viability, the double knockdown of both genes
by small interfering RNA (siRNA) results in cell lethality (Agrelo
et al., 2009; Savarese et al., 2009). Differences in the effects of
siRNA-mediated downregulation and targeted gene inactivation
on ES cell pluripotency were reported for the REST gene (Buck-
ley et al., 2009; Jørgensen et al., 2009; Jørgensen and Fisher,
2010; Singh et al., 2008). To date, no gene has been identified
that is required for XCI in ES cells but not in mice, which is not
surprising because ES cells serve as a bona fide model for the
molecular mechanism of XCI in early embryos (Lee et al., 1996;
Wutz and Jaenisch, 2000). However, the influence of the plurip-
otency machinery on XCI and the functional relationship
between Nanog, Oct4, and the expression of Xist in ES cells
have not yet been addressed in embryos (Donohoe et al.,868 Developmental Cell 23, 866–871, October 16, 2012 ª2012 Elsevier Inc.2009; Navarro et al., 2008, 2010). More-
over, the developmental window in which
pluripotent cells are present in the
embryo is temporally limited, whereas
the maintenance of the pluripotent state
is the defining hallmark of ES cells (Jae-
nisch and Young, 2008; Silva and Smith,
2008).
Satb1 and Satb2 Are Dynamically
Expressed during ES Cell
Differentiation
The finding that the ability for Xist to
initiate chromosomal silencing is limited
to the first few days of ES cell differentia-
tion provided an understanding of the
cellular basis of XCI and explained the
regulation of this process by factors like
Nanog and Oct4 (Donohoe et al., 2009;
Navarro et al., 2008, 2010; Wutz and Jae-
nisch, 2000; Wutz et al., 2002). Therefore,
the expression and/or activity of a factor
that is solely involved in regulating XCI
would have to be limited to undifferenti-
ated ES cells and the earliest stages of
ES cell differentiation (Brockdorff, 2009).
Although Satb1 and Satb2 were reportedto be expressed in this way (Agrelo et al., 2009), we failed to
observe a decrease of Satb1 RNA and protein expression under
various differentiation conditions (Savarese et al., 2009). Immu-
noblot analysis with a newly available monoclonal anti-Satb1
antibody indicated that Satb1 protein expression is augmented
at the onset of retinoic acid-induced differentiation of ES cells
and is not significantly altered during further differentiation (Fig-
ure 3A). In this experiment, two different wild-type ES cell lines,
including the germline-competent cell line W4 and an ES cell
line that allows for selection of undifferentiated or differentiated
cells (Savarese et al., 2009), were used to monitor Satb1 protein
levels during differentiation. The maintenance of Satb1 expres-
sion during ES cell differentiation was also observed with the
polyclonal anti-Satb1 antiserum (Figure S2D).
Moreover, Satb1 expression does not simply correlate with
the Xi silencing competence of developing thymocytes, which
is found in CD4+CD8+ cells but not in earlier-stage CD4CD8
cells or in later-stage CD4CD8+ and CD4+CD8 cells (Savarese
et al., 2006). Satb1 was identified as a gene that is down-
regulated in Xist-resistant thymic lymphoma cells relative to
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Figure 2. X Chromosomal Gene Silencing Is
Normal in the Absence of Satb1 and Satb2
Quantitative RT-PCR analysis of the indicated
transcripts reveals that the X-linked genes Pgk1
and Hprt are not de-repressed in MEFs from
female embryos lacking either Satb1(Satb1/),
Satb2 (Satb2/), or both Satb1 and Satb2
(Satb1Satb2dn). Results from MEFs of two
Satb1Satb2dn embryos are shown. The auto-
somal gene Gapdh serves as a control, demon-
strating no dosage imbalance between X-linked
and autosomal transcripts. Quantitative RT-PCR
analysis of Xist demonstrates that Satb1 and
Satb2 are not required for proper Xist expression.
Error bars indicate standard deviation (SD).
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Proper XCI in the Absence of Satb ProteinsXist-responsive thymic lymphoma cells (Agrelo et al., 2009).
However, all stages of differentiating T cells express significantly
higher Satb1 levels than ES cells, and abundant Satb1 expres-
sion is detected in the silencing-incompetent mature CD4+CD8
and CD4CD8+ thymocytes (Figures 3B–3D).
Molecular Mediators of XCI: Pluripotency Genes,
Nuclear Matrix, or Factor ‘‘X’’?
Although the induction of Xist responsiveness in Satb1-overex-
pressing cells supports a role of Satb1 in the initiation of X inacti-
vation, what could account for the absence of an X inactivation
defect in MEFs derived from female Satb1/Satb2/ embryos
and the development of female Satb1/Satb2/ embryos?
Our data do not favor the simplest possibility that Satb1/
Satb2/ embryos produce residual, possibly truncated or alter-
native forms of Satb1 and Satb2. However, Satb proteins could
influence XCI indirectly via the activation of the pluripotency
machinery. The pluripotency marker and transcription factor
Rex-1 is induced by Satb2 expression in cell fusions of ES cells
and human B lymphocytes (Savarese et al., 2009). Rex1 binds
and activates the Tsix gene (Navarro et al., 2010), and therefore
an indirect regulation of Tsix expression by Satb proteins may
influence XCI. Another possible explanation for the dispensable
function of Satb1 and Satb2 in XCI and the lack of a simple corre-
lation of the Xi silencing competence and Satb1 expression is
a redundancywithayet-unidentifieddeterminantofX inactivation.
A potential candidate for a protein that may compensate for the
combined loss of Satb1 and Satb2 is SAF-A (hnRNP-U), which
was demonstrated to mark the inactive X (Hasegawa et al.,
2010; Helbig and Fackelmayer, 2003; Nakagawa and Prasanth,
2011; Pullirsch et al., 2010). Similar to Satb1 and Satb2, SAF-A
has been previously identified as a protein that binds to nuclear
matrix attachment regions (Hart and Laemmli, 1998; Scheuer-
mann and Garrard, 1999). Proteins that bind to nuclear matrix
regionshavebeenproposed tomediate long-rangechromosomalDevelopmental Cell 23, 866–871,interactions; despite gene-specific func-
tions of Satb proteins, the common prop-
erty of binding to nuclear matrix attach-
ment regions may account for a potential
redundancy of Satb proteins and SAF-A
in X chromosome inactivation (Nakagawa
and Prasanth, 2011). However, the ex-
pression of SAF-A does not also mirror Xisilencing competence, suggesting that another yet-unidentified
protein may be involved in X chromosome inactivation.
EXPERIMENTAL PROCEDURES
RNA FISH and Immunofluorescence
MEFs were plated the previous day on gelatinized slides for immunofluores-
cence and RNA FISH experiments. RNA FISH was performed as described
previously (Gribnau et al., 1998). In brief, cells were fixed with 4% form-
amide/5% acetic acid/0.9% NaCl at room temperature for 18 min, washed
with PBS, and permeabilized with 0.01% pepsin digestion in 0.01 M HCl for
5 min at 37C. Cells were postfixed with 3.7% formamide at room temperature
for 5min. The slides were washedwith PBS and dehydratedwith ethanol baths
prior to hybridization. Hybridization was performed overnight at 37C using
a Xist cDNA probe Cy3-labeled by random priming with a Prime-It II kit (Stra-
tagene). Immunofluorescence was performed as described previously (Zinner
et al., 2006) using a rabbit antibody specific for H3K27me3 (kindly provided by
Thomas Jenuwein), which was detected by making use of an anti-rabbit IgG
antibody coupled to Alexa-488 or Alexa-568 (Molecular Probes). Nuclear
counterstaining was performed with DAPI (4’,6’-diamidino-2-phenylindole).
Immunoblot Analysis and Quantitative PCR
Immunoblotting was essentially performed as described (Dobreva et al., 2006),
using a polyclonal anti-Satb1 antiserum (Agrelo et al., 2009) or a monoclonal
anti-Satb1 antibody (Abcam, ab92307). Antibody dilutions were always
prepared freshly. RNA isolation was performed by TRIZOL extraction (Invitro-
gen) following manufacture’s instructions. We used 1 mg RNA for subsequent
reverse transcription. For the cDNA synthesis, 200 U SuperscriptII (Invitrogen)
was used with random hexamers. Real-time PCR was performed with SYBR
GREEN PCR master mix (Applied Biosystems) using the ABI PRISM 7000
sequence detection system. The cycle numbers were normalized to Tbp.
The following primers were used for detection of cDNA transcripts:
Hprt forward: ttcttctcagaccgctttt, Hprt reverse: cctggttcatcatcgctaatc
Pgk1 forward: tacctgctggctggatgg, Pgk1 reverse: cacagcctcggcatatttct
Gapdh forward: acagccgcatcttcttgtgc, Gapdh reverse: cactttgccactgc
aaatgg
Tbp forward: ggggagctgtgatgtgaagt,Tbp reverse: ccaggaaataattctggctcat
Xist: forward: catcgcccatcggtgctttttatgg, Xist reverse: ctaagccgagttatgc
ggcaagtctOctober 16, 2012 ª2012 Elsevier Inc. 869
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Figure 3. Dynamics of Satb Protein Expression in Differentiating ES
Cells and Lymphoid Cells
(A) Immunoblot analysis to detect Satb1 in wild-type (WT)Oct4-HygTK ES cells
(Savarese et al., 2009) and in W4 ES cells shows that Satb1 expression is
induced and maintained upon differentiation.
(B) Scheme displaying the transient appearance of Xist-responsive cells during
T cell development (Savarese et al., 2006).
(C) Immunoblot analysis of Satb1 expression demonstrates that Satb1 is
abundantly expressed in both silencing-incompetent CD4CD8 cells and in
silencing-competent CD4+CD8+ cells, indicating that Satb1 expression does
not distinguish these two cell types. CD4CD8 cells express even higher
levels of Satb1 than silencing-competent ES cells.
(D) Quantitative RT-PCR analysis of Satb1 expression during T cell differ-
entiation reveals that Satb1 is abundantly expressed at all stages of T cell
development. Notably, silencing-incompetent single positive T cells contain
more Satb1 transcripts than CD4+CD8+ cells. Error bars refer to standard
deviation.
Developmental Cell
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Satb1 PDZ domain forward: AAGATTGCCCGCCTGGAGCA
Satb1 PDZ domain reverse: TTTGGCTTGGGCAGCAGAGCTG
Satb1 DNA-binding domain forward: CAGCTCTCTCACGGCAGTCA870 Developmental Cell 23, 866–871, October 16, 2012 ª2012 ElsevSatb1 DNA-binding domain reverse: TGGGATGCAGTCTTGGGGTC
Gapdh forward: GCCAGCCTCGTCCCGTAGACAAAA
Gapdh reverse: TGGGTGGCAGTGATGGCATG
Genotyping
Genotype determination of embryos and MEFs was performed by PCR as
described previously (Dobreva et al., 2006) on DNA isolated from cultured cells
or embryo tails.
Sly forward: tgcagggcaggggcgtatga, Sly reverse: cctgctgccacacctccagc
Satb1wt forward: tgatctgtaagacagtgactgagt, Satb1wt reverse: cctaaggtt
ggttttcatgagatggcc
Satb1mut forward: ccaagggaggaaggacaccaaaac, Satb1mut reverse: gttgg
cgcctaccggtggatgtg
Satb2 forward: cggtggggactttgtctcca, Satb2wt reverse: gccaccctctgggta
aaccac,
Satb2mut reverse: cgggaatcttcgctattacg
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